Axsome Therapeutics
AXSM
AXSM
35 hedge funds and large institutions have $13.1M invested in Axsome Therapeutics in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
62% less call options, than puts
Call options by funds: $55K | Put options by funds: $145K
Holders
35
Holding in Top 10
–
Calls
$55K
Puts
$145K
Top Buyers
| 1 | +$494K | |
| 2 | +$150K | |
| 3 | +$60K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$50K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$31.7K |
Top Sellers
| 1 | -$315K | |
| 2 | -$216K | |
| 3 | -$199K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$120K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$93.5K |